![Patrick James Doyle](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Patrick James Doyle
President chez
KINEMED INC
Profil
Patrick James Doyle currently works at TRIO Pharmaceuticals, Inc., as Chief Executive Officer from 2025 and KineMed, Inc., as President & Director from 2014.
Dr. Doyle also formerly worked at Stelexis Therapeutics LLC, as Chief Executive Officer from 2018 to 2021, Ipsen Bioinnovation Ltd., as Chief Executive Officer, CymaBay Therapeutics, Inc., as Chief Development Officer, Roche Ltd., as Vice President, and Novo Nordisk, Inc., as Scientific Coordinator.
Dr. Doyle received his undergraduate degree and doctorate degree from the University of Sunderland and graduate degree from the University of Geneva.
Postes actifs de Patrick James Doyle
| Sociétés | Poste | Début |
|---|---|---|
| KINEMED INC | President | 22/05/2014 |
TRIO Pharmaceuticals, Inc.
 TRIO Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Specializes in developing cancer drugs | Directeur Général | 18/07/2025 |
Anciens postes connus de Patrick James Doyle
| Sociétés | Poste | Fin |
|---|---|---|
Stelexis Therapeutics LLC
 Stelexis Therapeutics LLC Pharmaceuticals: MajorHealth Technology Develops transformative therapies for the treatment of cancer to target pre-cancerous stem cells | Directeur Général | 01/05/2021 |
Ipsen Bioinnovation Ltd.
 Ipsen Bioinnovation Ltd. BiotechnologyHealth Technology Engages in research and experimental development on biotechnology | President | - |
Novo Nordisk, Inc.
 Novo Nordisk, Inc. BiotechnologyHealth Technology Develops biological medicines | Corporate Officer/Principal | - |
Roche Ltd.
 Roche Ltd. Financial ConglomeratesFinance Provides investment services | Corporate Officer/Principal | - |
| CYMABAY THERAPEUTICS, INC. | Corporate Officer/Principal | - |
Formation de Patrick James Doyle
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
16
Relations au 1er degré
9
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 9 |
|---|---|
KineMed, Inc.
 KineMed, Inc. Miscellaneous Commercial ServicesCommercial Services Develops and commercializes biomarker platform technology | Commercial Services |
CymaBay Therapeutics, Inc.
 CymaBay Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutics for people with life-threatening diseases | Health Technology |
University of Sunderland
 University of Sunderland Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Geneva
 University of Geneva Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Roche Ltd.
Roche Ltd. Financial ConglomeratesFinance Provides investment services | Finance |
Novo Nordisk, Inc.
Novo Nordisk, Inc. BiotechnologyHealth Technology Develops biological medicines | Health Technology |
Ipsen Bioinnovation Ltd.
Ipsen Bioinnovation Ltd. BiotechnologyHealth Technology Engages in research and experimental development on biotechnology | Health Technology |
Stelexis Therapeutics LLC
Stelexis Therapeutics LLC Pharmaceuticals: MajorHealth Technology Develops transformative therapies for the treatment of cancer to target pre-cancerous stem cells | Health Technology |
TRIO Pharmaceuticals, Inc.
TRIO Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Specializes in developing cancer drugs | Health Technology |
